A carregar...
Microfluidics in Malignant Glioma Research and Precision Medicine
Glioblastoma multiforme (GBM) is an aggressive form of brain cancer that has no effective treatments and a prognosis of only 12–15 months. Microfluidic technologies deliver microscale control of fluids and cells, and have aided cancer therapy as point-of-care devices for the diagnosis of breast and...
Na minha lista:
| Publicado no: | Adv Biosyst |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5959050/ https://ncbi.nlm.nih.gov/pubmed/29780878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adbi.201700221 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|